Hester Biosciences informs about transcript of earnings conference call

07 Nov 2022 Evaluate

Pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hester Biosciences has informed that it attached the transcript of the earnings conference call held by the management of the Company with investors on Friday, 4 November 2022 at 2:00 pm (IST) to discuss the unaudited financial results for the quarter and half year ended 30 September 2022.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

2395.00 24.85 (1.05%)
23-Dec-2024 15:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1815.30
Dr. Reddys Lab 1341.20
Cipla 1475.85
Lupin 2161.05
Zydus Lifesciences 971.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.